Reducing medicine-induced deterioration and adverse reactions (ReMInDAR) trial: study protocol for a randomised controlled trial in residential aged-care facilities assessing frailty as the primary outcome

Reducing medicine-induced deterioration and adverse reactions (ReMInDAR) trial: study protocol for a randomised controlled trial in residential aged-care facilities assessing frailty as the primary outcome

Introduction Many medicines have adverse effects which are difficult to detect and frequently go unrecognised. Pharmacist monitoring of changes in signs and symptoms of these adverse effects, which we describe as medicine-induced deterioration, may reduce the risk of developing frailty. The aim of t...

Full description

Saved in:
Bibliographic Details
Main Authors: Nicole L Pratt, Lisa M Kalisch Ellett, Elizabeth Ellen Roughead, Renly Lim, Megan Corlis, Gaynor Parfitt, Debra Rowett, Luke Bereznicki, Ai Choo Kang, Tracy Merlin, Stacey Torode, Joseph Whitehouse, Andre Q Andrade, Rebecca Bilton, Justin Cousins, Lan Kelly, Camille Schubert, Mackenzie Williams
Format: Article
Language:English
Published: BMJ Publishing Group 2020-04-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/10/4/e032851.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://bmjopen.bmj.com/content/10/4/e032851.full

Similar Items